Corrigendum to "Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study” [Vaccine: X 11 (2022) 100189]

Sáez-Llorens, Xavier; Lanata, Claudio; Aranguren, Elaine; Celis, Carlos R.; Cornejo, Rubelio; DeAntonio, Rodrigo; Ecker, Lucie; Garrido, Diegi; Gil, Ana I.; Gonzales, Marina; Hess-Holtz, Morgan; Leroux-Roels, Geert; Junker, Helga; Kays, Sarah-Katharina; Koch, Sven D.; Lazzaro, Sandra; Mann, Philipp; Quintini, Gianluca; Srivastava, Barkha; Vahrenhorst, Dominik; von Eisenhart-Rothe, Philipp; Wolz, Olaf-Oliver; Oostvogels, Lidia

Sáez-Llorens, Xavier; Lanata, Claudio; Aranguren, Elaine; Celis, Carlos R.; Cornejo, Rubelio; DeAntonio, Rodrigo; Ecker, Lucie; Garrido, Diegi; Gil, Ana I.; Gonzales, Marina; Hess-Holtz, Morgan; Leroux-Roels, Geert; Junker, Helga; Kays, Sarah-Katharina; Koch, Sven D.; Lazzaro, Sandra; Mann, Philipp; Quintini, Gianluca; Srivastava, Barkha; Vahrenhorst, Dominik; von Eisenhart-Rothe, Philipp; Wolz, Olaf-Oliver; Oostvogels, Lidia.

Vaccine: X ; 14:100307-100307, 2023.

Article in English | EuropePMC | ID: covidwho-2302905

Search on Google

XML

Collection: Databases of international organizations Database: EuropePMC Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines Language: English Journal: Vaccine: X Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML